Obesity Featured Articles
-
What It Takes To Validate A Biomarker For Real-World, Post-Transplant Care
8/7/2026
Yelena Bushman, MBA, VP of cell therapy and transplant at CareDx, discusses the operational challenges of validating biomarkers for post-transplant care.
-
July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing
8/7/2026
Mathini Ilancheran updates us on how delayed U.S. tariffs on generic drug imports could reshape supply, sourcing, and trial planning.
-
Traditional, Hybrid Or Decentralized: What Actually Works?
8/6/2026
Learn how traditional, decentralized, and community-based approaches address different study challenges and support more effective, patient-centered research.
- Castor Services 8/6/2026
-
Driving Engagement, Improving Outcomes: The Impact Of Virtual Registered Dietitian Support In Metabolic Trials
8/5/2026
Traditional, decentralized, and hybrid trial models each offer unique benefits. The right approach can strengthen recruitment, retention, data quality, and study success.
-
C-Suite Changes Help Biotech Narrow Focus But Maintain Drive To Treat Fatal Neonatal Brain Injury
8/5/2026
Newly-appointed leaders at ReAlta Life Sciences discuss their skill sets, their goals for advancing a therapy for hypoxic ischemic encephalopathy (HIE), and how they keep momentum as they strive to help bring this potentially lifesaving therapy to market.
-
Accelerating Psychedelic Therapeutics: A Regulatory Inflection Point In Mental Health
8/4/2026
A 2026 executive order is fast-tracking psychedelic therapies for depression, PTSD, and addiction. Understand what this regulatory shift means for your next clinical trial.
-
3 Ways To Solve Data Friction In Modern Clinical Data Management
8/4/2026
Senior clinical data manager Shasidar Reddy Abbidi shares how to reduce data friction with targeted automation, early standards adoption, and clearer workflows that move data to decisions faster.
-
How Visible Is Your Clinical Trial To AI?
8/3/2026
Ross Jacksons explores how clinical trials show up — it at all — in AI tools and what that means for sponsors' approach to publicizing trial information.
-
The Rare Trials Summit Wants To Produce More Than Conversation
8/3/2026
The Rare Trials Summit returns to Boston this September with a mission that extends beyond traditional conference presentations. Through interactive workshops and working groups focused on regulatory guidance and pediatric trials, organizers hope to produce practical solutions that help advance rare disease clinical research.